{
    "code": 0,
    "data": [
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Declaration Of Un-Audited Financial Results For The Quarter Ended 31St December 2025",
            "news_body": "Outcome of Board meeting held on 15th January 2026 for declaration of Un-Audited Financial results of the Company for the quarter ended 31st December 2025",
            "news_id": "47f6d2c1-824b-4578-847e-b09b48d202b1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8e761af5-adeb-4ec6-9b55-862f26c2d29f.pdf",
            "news_date": "2026-01-15 18:00:09",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Declaration Of Un-Audited Financial Results For The Quarter Ended 30Th September 2025",
            "news_body": "Board meeting held on 20th September 2025 to approve un-audited Financial results of the Company for the quarter ended 30th September 2025",
            "news_id": "c00e30e4-bd88-4962-8bff-a488777fe7d9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=79504818-5127-47b5-b291-137999507c8c.pdf",
            "news_date": "2025-11-20 20:13:04",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Delay in Financial Results",
            "news_body": "Intimation regarding delay in declaration of Financial results of the Company for the quarter ended 30th September 2025.",
            "news_id": "f2a5244e-40a9-4fd2-9e2d-2e56f11ae294",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=191e47b8-834f-4583-ba6c-3d55c9144f7e.pdf",
            "news_date": "2025-11-13 18:44:23",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Approval Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended 30Th June 2025",
            "news_body": "Board meeting held on 7th August 2025 at 4:00 p.m. to approve un-audited financial results (standalone and consolidated) for the quarter ended 30th June 2025",
            "news_id": "a185b26e-c01a-4492-977c-a1891785410f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=18b7419f-f602-4a5d-9d1e-adaa40b02b91.pdf",
            "news_date": "2025-08-07 21:56:12",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Approval Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended 30Th June 2025",
            "news_body": "Board meeting held on 7th August 2025 at 4:00 p.m. to approve un-audited financial results (standalone and consolidated) for the quarter ended 30th June 2025",
            "news_id": "23b5de9d-6953-4da0-995b-f0a2aa61a972",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c75f665e-125a-42a5-b368-94acc4d2071a.pdf",
            "news_date": "2025-08-07 21:54:53",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Approval Of Financial Results For The Quarter And Year Ended 31St March 2025",
            "news_body": "Outcome of board meeting held on 17th May 2025 for approval of Audited Financial Results for the quarter ended 31st March 2025",
            "news_id": "774c5d44-67b9-4531-8637-6b5afd70ff4d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e1d65f51-a469-4a58-8983-704c6555b157.pdf",
            "news_date": "2025-05-17 23:58:07",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Declaration Of Un-Audited Financial Results For The Quarter Ended 31St December 2024",
            "news_body": "Board meeting held on 13th February 2025 for declaration of Un-Audited Financial Results of the Company For the quarter ended 31st December 2024.",
            "news_id": "f99be743-324f-4771-93f2-0bfc70450add",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=08bb68bb-d8dc-41c9-b0f0-e3396753266e.pdf",
            "news_date": "2025-02-13 19:56:25",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Standalone And Consolidated Financial Results For The Quarter Ended 30Th September, 2024",
            "news_body": "Board meeting held on 14 th November 2024 for declaration of Un-audited Standalone and Consolidated Financial Results for the quarter ended 30th September, 2024",
            "news_id": "012565a3-9c2e-4cb3-a459-0859ab382045",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6034a3e2-b62a-4432-8705-7e88ba896e1b.pdf",
            "news_date": "2024-11-14 19:15:44",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Approval Of Standalone And Consolidated Un-Audited Financial Results For The Quarter Ended 30.06.2024",
            "news_body": "Approval of Standalone and consolidated Un-audited financial results of the Company for the quarter ended 30.06.2024",
            "news_id": "617bcffb-2072-435f-a251-09c45076dfd7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b9b3fe7e-fb3f-4219-879f-12cdd9551bf4.pdf",
            "news_date": "2024-08-13 19:53:05",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "FINANCIAL RESULTS FOR THE PERIOD ENDED MARCH 31 2024 AND OTHER AGENDA ITEMS",
            "news_body": "FINANCIAL RESULTS FOR THE PERIOD ENDED MARCH 31 2024 AND OTHER AGENDA ITEMS",
            "news_id": "0609cd90-1b45-409d-9f21-5d631a6217b4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b67c964b-14ae-4db7-91b6-0a7d4034c306.pdf",
            "news_date": "2024-05-21 19:35:24",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended 31St December 2023",
            "news_body": "Submission of Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December 2023",
            "news_id": "c646c0ec-3c34-4393-a311-bbdf37d03be3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e48f3e49-744e-4d33-bec9-6186fcc7da9b.pdf",
            "news_date": "2024-02-13 19:39:04",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of The Revised Consolidated Statement Of Unaudited Financial Results, Statement Of Assets And Liabilities And Statement Of Cash Flow For The Period Ended September 30, 2023",
            "news_body": "Submission of Revised Consolidated Statement of Unaudited Financial Results, Statement of Assets and Liabilities and Cash Flow Statement for the period ended 30.09.2023",
            "news_id": "8f697b06-0aac-4c7f-8856-84a4f34e59e4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7632df7b-d9b0-4b8d-a019-d2336e31ab22.pdf",
            "news_date": "2024-01-16 20:32:30",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Consolidated Cash Flow Statement For The Period Ended 30Th September 2023",
            "news_body": "Submission of Consolidated Cash Flow Statement for the period ended 30th September 2023",
            "news_id": "83103e0c-e2a3-4cf1-8705-56efbd431576",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0e05d7c0-7229-40f4-b7f6-0bdab98f628c.pdf",
            "news_date": "2024-01-04 14:31:34",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 30.09.2023",
            "news_body": "Standalone and consolidated financial results for the period ended 30.09.2023",
            "news_id": "e7ee4daa-0e66-43a4-82d7-bc89933e8d57",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=887172ff-4ed7-43ea-9736-2f2c8092d30a.pdf",
            "news_date": "2023-11-08 20:02:49",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended June 30 2023",
            "news_body": "Unaudited financial results for the quarter ended June 30 2023 along with the Limited review report on the same.",
            "news_id": "91f22fe7-ee3a-4c55-bb50-7821aecba6f4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=745d454e-7d7f-4539-8146-0ef1ce0f32eb.pdf",
            "news_date": "2023-08-10 17:50:11",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "FINANCIAL RESULTS FOR THE FINANCIAL YEAR ENDED 31ST MARCH 2023",
            "news_body": "With respect to the captioned subject and mentioned reference, we are pleased to inform that the Board of Directors of the Company, in their meeting held today i.e., Tuesday, May 30, 2023 has inter-alia transacted the following business:  The Audited Financial Results (Standalone) for the quarter and Financial Year ended March 31, 2023 pursuant to Regulation 33 of the SEBI LODR Regulations. (A copy of the said results, notes thereto and Auditor's Report is annexed hereto and marked as Annexure I.)",
            "news_id": "c3e15c86-5e94-4ad8-a425-6a745f44a573",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=01e50800-ba58-4695-a531-f243621db8dd.pdf",
            "news_date": "2023-05-30 18:56:58",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results- For The Period Ended DECEMBER 31, 2022",
            "news_body": "Pursuant to Regulation 30 read with part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (the Listing Regulations) we wish to inform that the Board of Directors of the Company at its meeting held today i.e., February 13, 2023 inter-alia transacted the following business:1. Considered & approved the Un-Audited Financial Results for the period ended December 31st, 2022 along with the Limited Review Report on the un-audited results pursuant to Regulation 33 of the Listing Regulations;",
            "news_id": "5ee3a9ba-5f9c-4b97-a33a-a8e2e363f8bc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3296a7c8-70b3-4ae8-9719-3b8baa2d3ab5.pdf",
            "news_date": "2023-02-13 19:06:15",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Compliance Under Regulation 23(9) Of The SEBI (Listing      Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith disclosure of Related Party Transactions, for the period ended September 30, 2022.",
            "news_id": "9bcd59ed-4afb-4b70-960b-56f104ee7f32",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b6dc4796-328d-4439-a901-338b62e85262.pdf",
            "news_date": "2022-11-22 13:47:40",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On Friday, November 11, 2022",
            "news_body": "Pursuant to Regulation 30 read with part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (the Listing Regulations) we wish to inform that the Board of Directors of the Company at its meeting held today i.e., November 11, 2022 transacted the following business:<BR> <BR> 1. Considered & approved the Un-Audited Financial Results for the period ended September 30th, 2022 along with the Limited Review Report on the results pursuant to Regulation 33 of the Listing Regulations;",
            "news_id": "873adae9-5332-4771-85f4-d48f428ab62a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d4cb5853-87a6-4c5f-be84-498a47988f73.pdf",
            "news_date": "2022-11-11 15:55:30",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Amended Policy On Criteria For Determining Materiality Of Events As Per Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements), Regulations, 2015 (Annexure C).",
            "news_body": "Amended Policy on Criteria for Determining Materiality of Events as per Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements), Regulations, 2015 (Annexure C).",
            "news_id": "da074a85-cc23-40ed-a22d-ad3ef0310c28",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ef4aba85-ca35-4276-9869-0d9c45a70567.pdf",
            "news_date": "2022-08-05 17:26:01",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Unaudited Financial Results For The Quarter Ended June 30, 2022",
            "news_body": "Pursuant to Regulation 30 read with part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (the Listing Regulations) we wish to inform that the Board of Directors of the Company at its meeting held today i.e., August 5, 2022 inter-alia transacted the following business:<BR> <BR> 1. Considered & approved the Un-Audited Financial Results for the quarter ended June 30th, 2022 along with the Limited Review Report on the results pursuant to Regulation 33 of the Listing Regulations; (Annexure A)<BR>",
            "news_id": "a82c18db-c406-4f79-9b5c-a5cf4a2449f1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26cb6f76-509e-4808-95e7-350f9471c5db.pdf",
            "news_date": "2022-08-05 17:13:01",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Unaudited Financial Results For The Quarter Ended June 30, 2022",
            "news_body": "Pursuant to Regulation 30 read with part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (the Listing Regulations) we wish to inform that the Board of Directors of the Company at its meeting held today i.e., August 5, 2022 inter-alia transacted the following business:<BR> <BR> 1. Considered & approved the Un-Audited Financial Results for the quarter ended June 30th, 2022 along with the Limited Review Report on the results pursuant to Regulation 33 of the Listing Regulations; (Annexure A)<BR>",
            "news_id": "4adf3519-4094-457d-8aed-d1c376032850",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4f48f83b-c5f5-4195-b402-82e5fbaf96d5.pdf",
            "news_date": "2022-08-05 17:12:10",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Friday, August 5, 2022",
            "news_body": "Pursuant to Regulation 30 read with part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (the Listing Regulations) we wish to inform that the Board of Directors of the Company at its meeting held today i.e., August 5, 2022 inter-alia transacted the following business:<BR> <BR> 1. Considered & approved the Un-Audited Financial Results for the quarter ended June 30th, 2022 along with the Limited Review Report on the results pursuant to Regulation 33 of the Listing Regulations; (Annexure A)<BR> 2. Amended Code of Conduct for Regulating, Monitoring and Reporting of Trading by Designated persons and immediate relatives of Designated persons in the securities of the company as per Regulation 9 of SEBI (Prohibition of Insider Trading), Regulations, 2015; (Annexure B)<BR> 3. Amended Policy on Criteria for Determining Materiality of Events as per Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements), Regulations, 2015 (Annexure C).<BR>",
            "news_id": "329eeb88-0d93-484c-ab30-9c1e2013e2c1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e415ab2-f6be-4f4d-a5ec-c2ff2ed54b88.pdf",
            "news_date": "2022-08-05 17:05:15",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Compliance Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith disclosure of Related Party Transactions, for the period ended March 31, 2022. Kindly take the above information on your records.",
            "news_id": "df8b71e2-4e23-4b56-9fb5-7083f3bf88ce",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3ab40aaf-012c-4b47-9810-399498f48f5b.pdf",
            "news_date": "2022-06-06 17:05:02",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "We Are Pleased To Inform That The Board Of Directors Of The Company, In Their Meeting Held Today I.E., Thursday, May 26, 2022 Has Inter-Alia Transacted The Following Business:The Audited Financial Results (Standalone) For The Quarter And Financial Year Ended March 31, 2022 Pursuant To Regulation 33 Of The SEBI LODR Regulations. (A Copy Of The Said Results, Notes Thereto And Auditor'S Report Is Annexed Hereto And Marked As Annexure I.)",
            "news_body": "we are pleased to inform that the Board of Directors of the Company, in their meeting held today i.e., Thursday, May 26, 2022 has inter-alia transacted the following business:The Audited Financial Results (Standalone) for the quarter and Financial Year ended March 31, 2022 pursuant to Regulation 33 of the SEBI LODR Regulations. (A copy of the said results, notes thereto and Auditor's Report is annexed hereto and marked as Annexure I.)",
            "news_id": "bee5e2ae-0e52-47ff-8e6a-2b6afaa428ff",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6950bbb2-0a8e-4bec-b5ea-07414de35e6a.pdf",
            "news_date": "2022-05-26 19:02:51",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On Thursday, May 26, 2022",
            "news_body": "we are pleased to inform that the Board of Directors of the Company, in their meeting held today i.e., Thursday, May 26, 2022 has inter-alia transacted the following business:The Audited Financial Results (Standalone) for the quarter and Financial Year ended March 31, 2022 pursuant to Regulation 33 of the SEBI LODR Regulations. (A copy of the said results, notes thereto and Auditor's Report is annexed hereto and marked as Annexures)",
            "news_id": "fd093370-ca39-44f2-9504-bba90106212a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=77d63101-9312-4d53-9905-0239658d0973.pdf",
            "news_date": "2022-05-26 18:59:59",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Financial Results For The Quarter And Nine Months Ended December 31, 2021",
            "news_body": "Un-Audited Financial Results for the quarter and nine months ended December 31, 2021",
            "news_id": "b6055152-4154-4bf8-82b5-45362cb7e2ff",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=78247bfb-8648-476e-97de-e0a5e04c62bd.pdf",
            "news_date": "2022-02-04 17:18:14",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Friday, February 4, 2022",
            "news_body": "Outcome of Board Meeting held on Friday, February 4, 2022",
            "news_id": "65f88b4b-7bf9-4080-957e-a0bb70704d8f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3b3c17d1-f029-4e8c-93c7-5b13ec0cc36b.pdf",
            "news_date": "2022-02-04 17:12:26",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Related Party Transactions Under Regulation 23(9) Of The SEBI Listing Regulations, 2015 For The Half Year Ended September 30, 2021.",
            "news_body": "Related Party Transactions under Regulation 23(9) of the SEBI Listing Regulations, 2015 for the half year ended September 30, 2021.",
            "news_id": "731eaa76-51b6-4fc2-8491-962dac0abd8b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1917d218-3326-415e-808a-c037e36cb054.pdf",
            "news_date": "2021-12-10 12:24:29",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Standalone Un-Audited Financial Results For The Quarter And Half Year Ended September 30, 2021.",
            "news_body": "Pursuant to Regulation 30 read with part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (the Listing Regulations) we wish to inform that the Board of Directors of the Company at its meeting held today i.e., November 12, 2021 inter-alia considered & approved the Un-Audited Financial Results for the quarter and half year ended September 30, 2021 along with the Limited Review Report on the results pursuant to Regulation 33 of the Listing Regulations. A copy of the said results, notes thereto and Limited Review Report of the Auditor is enclosed for your records.",
            "news_id": "b655c693-42e3-48f3-8a79-563c8208d676",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eeb4bad7-8a6d-4906-bbc2-d9ea288c421a.pdf",
            "news_date": "2021-11-12 16:53:45",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Financial Results For The Quarter Ended June 30, 2021.",
            "news_body": "Un-audited Financial Results for the quarter ended June 30, 2021.",
            "news_id": "8b224d69-3786-434d-b8ef-6c6ab0d0caca",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f1657a51-3f64-47f6-a5bc-74ae707fdbd4.pdf",
            "news_date": "2021-08-12 17:51:08",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday, August 12, 2021.",
            "news_body": "Outcome of Board Meeting held on Thursday, August 12, 2021.",
            "news_id": "b33184cf-81f4-4291-b9b3-7f1d846873b0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=818d685e-d919-443b-a38a-b32c1e32a52c.pdf",
            "news_date": "2021-08-12 17:46:17",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Compliance Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.",
            "news_body": "In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed<BR> herewith disclosure of Related Party Transactions, in the format specified in the accounting standards for the year ended March 31, 2021.",
            "news_id": "8f905d76-5606-4e51-abba-0a001044cb90",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8905f5ac-6715-45da-86a6-fbe1d41fe840.pdf",
            "news_date": "2021-06-11 14:44:40",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results (Standalone) For The Quarter And Year Ended March 31, 2021.",
            "news_body": "Audited Financial Results (Standalone) for the quarter and year ended March 31, 2021.",
            "news_id": "b122e47a-af27-4360-9f34-771773f2aa4d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=971db30b-cf9b-474f-9a79-34c483f7753a.pdf",
            "news_date": "2021-05-20 16:39:40",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANGALAM",
            "disp": "Mangalam Drugs & Organics",
            "bse_code": 532637,
            "isin": "INE584F01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held On Thursday, May 20, 2021",
            "news_body": "Outcome of the Board Meeting held on Thursday, May 20, 2021",
            "news_id": "335b8343-83c9-4756-9b5d-cc0078b97073",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b84018dc-9052-4825-a838-65291869db7a.pdf",
            "news_date": "2021-05-20 16:33:07",
            "seo": "mangalam-drugs-and-organics-ltd",
            "ltp": 34.57,
            "ch": 1.2899999999999991,
            "pch": 3.8762019230769202,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11820,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}